$4.78
0[0.00%]
Last update: 8:15AM Get Real Time Here
Fate Therapeutics
(NASDAQ:FATE)Fate Therapeutics Stock (NASDAQ:FATE), Quotes and News Summary
Fate Therapeutics Stock (NASDAQ: FATE) stock price, news, charts, stock research, profile.
| Open | $4.790 |
| Close | - |
| Volume / Avg. | 524.348K / 2.778M |
| Day Range | 4.750 - 5.020 |
| 52 Wk Range | 1.630 - 8.830 |
| Market Cap | $543.883M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 25 |
| Short Interest | 17.9% |
| Days to Cover | 6.7 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Fate Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It i...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Fate Therapeutics (FATE) stock?
You can purchase shares of Fate Therapeutics (NASDAQ: FATE) through any online brokerage.
Who are Fate Therapeutics's (FATE) competitors?
Other companies in Fate Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Korro Bio (NASDAQ:KRRO) and Altimmune (NASDAQ:ALT).
What is the target price for Fate Therapeutics (FATE) stock?
The latest price target for Fate Therapeutics (NASDAQ: FATE) was reported by Needham on Thursday, April 11, 2024. The analyst firm set a price target for 0.00 expecting FATE to fall to within 12 months (a possible -100.00% downside). 22 analyst firms have reported ratings in the last year.
Current Stock Price for Fate Therapeutics (FATE)?
The stock price for Fate Therapeutics (NASDAQ: FATE) is $4.805 last updated Today at April 23, 2024 at 11:13 AM EDT.
Does Fate Therapeutics (FATE) pay a dividend?
There are no upcoming dividends for Fate Therapeutics.
When is Fate Therapeutics (NASDAQ:FATE) reporting earnings?
Fate Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
Is Fate Therapeutics (FATE) going to split?
There is no upcoming split for Fate Therapeutics.
What sector and industry does Fate Therapeutics (FATE) operate in?
Fate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.